Specifically, 6 (14.6%), 20 (48.8%), and 7 (17.1%) participants with LADA and 2 (2.2%), 21 (23.3%), and 10 (11.1%) of those with T1D tested positive for AAb-IFN-α1 (P = .012; Supplementary Fig. S2A) to AAb-IFN-α2 (P = .0036; Supplementary Fig. S2B) and to AAb-IFN-α14 (P = .40; Supplementary Fig. S2C), respectively (16). The gene discussed is IFNA2; the disease is type 1 diabetes mellitus.